Prostate cancer Board decisions

The Veteran's appeal for an evaluation in excess of 60 percent for prostate cancer has been dismissed due to his death. The Board does not have jurisdiction to proceed with the case.

The Board has remanded the claims for prostate cancer, hypertension, obesity, sleep apnea, lumbar spine disability, bilateral pes planus, left foot bunion, right foot bunion, left ankle disability (claimed as achilles tendonitis), left knee disability, right knee disability, left hand disability, right hand disability, left elbow disability, right elbow disability, left shoulder disability, and right shoulder disability due to incomplete military records.

The Veteran's prostate cancer disability, characterized by voiding dysfunction requiring absorbent materials changed 2-4 times per day, does not warrant a rating in excess of 40 percent from March 1, 2020.

The Board has determined that the Veteran's service connection claim for prostate cancer should be remanded due to a duty to assist error regarding exposure to herbicide agents during his military service.

The Board has granted service connection for diabetes mellitus, ischemic heart disease, residuals of prostate cancer, and hypothyroidism due to exposure to herbicides during the Veteran's military service. The conditions are on the presumptive disease list for exposure to herbicides under VA regulations.

The Veteran's PTSD symptoms result in occupational and social impairment with deficiencies in most areas, but not total occupational and social impairment. A 70 percent rating is granted for PTSD.

The Board denied the Veteran's claim for service connection for prostate cancer, finding no evidence of herbicide exposure and noting that prostate cancer was not diagnosed until decades after separation from service.

The appeal to reduce the Veteran's prostate cancer residuals from a 100% rating to a 20% rating is dismissed as there was no final agency action.

The Veteran's prostate cancer and ischemic heart disease are granted as service connected due to exposure to herbicide agents during his service at Don Muang Royal Thai Air Force Base in Thailand.

The Veteran's claims for service connection for prostate cancer and diabetes mellitus type II, both claimed to be due to herbicide agent exposure in Panama, are remanded. The claims for peripheral neuropathy of the lower extremities are also remanded as they are inextricably intertwined with the service connection issues.

The Board has decided to remand the case due to insufficient medical opinion regarding the etiology of the Veteran's prostate cancer.

The Veteran's claim for service connection for prostate cancer, associated with herbicide exposure, is granted effective July 17, 2022. This decision is based on the PACT Act of 2022 which added prostate cancer to the list of presumptive diseases.

Service connection for prostate cancer is granted. Service connection for bilateral hearing loss and tinnitus are denied.

The Board has remanded several issues related to service connection for chronic lymphocytic leukemia, prostate cancer, and hypertension due to potential reopening of the claims based on new evidence. The hearing loss issue remains denied.

The Veteran's claim for an initial compensable rating for his service-connected prostate cancer is remanded due to the inadequacy of a previous VA examination. The Board finds there was a pre-decisional duty to assist error and requires a new examination.

The Veteran's service-connected disabilities rendered him unable to secure and follow a substantially gainful occupation, meeting the criteria for a TDIU.

The Veteran's prostate cancer is granted service connection under the PACT Act due to presumed exposure. Service connection for subcutaneous B cell lymphoma is remanded as there was no medical examination or opinion provided.

The Veteran's bladder and prostate cancer recurrence is due to the lack of treatment or follow-up after April 2009 TURBT, which may have been caused by VA carelessness. The Board has ordered a remand for further analysis.

The Board denied service connection for kidney cancer and prostate cancer as there was no evidence of herbicide exposure or other link to service.

The Board has determined that the reduction from a 100% to a noncompensable rating for residuals of prostate cancer was proper based on evidence showing no active disease and the Veteran's ability to function under ordinary conditions.